Mach7 TechnologiesASX:M7T +3.39%35 PB Ratio is 1.84 as of Jun. 24, 2026, which is 21% below its 10-year median of 2.32. GuruFocus rates ASX:M7T with a GF Score™ of 35/100 and a GF Value™ of A$0.82 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Mach7 Technologies ranks better than 53.85% on this metric.
The historical rank and industry rank for Mach7 Technologies's PB Ratio or its related term are showing as below:
ASX:M7T'
s PB Ratio Range Over the Past 10 Years
Min: 0.44 Med: 2.32 Max: 14.85
Current: 1.84
During the past 13 years, Mach7 Technologies's highest PB Ratio was 14.85. The lowest was 0.44. And the median was 2.32.
ASX:M7T's PB Ratio is ranked better than 53.85% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.96
vs ASX:M7T: 1.84
During the past 12 months, Mach7 Technologies's average Book Value Per Share Growth Rate was -23.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -9.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -4.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 8.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Mach7 Technologies was 56.80% per year. The lowest was -73.80% per year. And the median was -0.95% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Mach7 Technologies PB Ratio Related Terms
Mach7 Technologies PB Ratio Historical Data
* Premium members only.
The historical data trend for Mach7 Technologies's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Mach7 Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mach7 Technologies PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where Mach7 Technologies's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Mach7 Technologies (ASX:M7T) has a PB Ratio of 1.84 as of Jun. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Mach7 Technologies and its competitors. This is 21% below median its historical median of 2.32. Over the past decade, Mach7 Technologies' PB Ratio has ranged from 0.44 to 14.85. According to the industry distribution chart, Mach7 Technologies ranks #282 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 46.2%.
Is Mach7 Technologies' PB Ratio too high?
Mach7 Technologies' current PB Ratio of 1.84 is 21% below median its 10-year median of 2.32. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 14.85. The Healthcare Providers & Services industry median PB Ratio is 1.96. Mach7 Technologies' value of 1.84 is 6.1% below this industry median. Based on the distribution chart, Mach7 Technologies ranks #282 out of 611 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Mach7 Technologies has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mach7 Technologies' PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mach7 Technologies ranks #282 out of 611 companies for PB Ratio. This puts Mach7 Technologies in the upper half of its industry. The industry median PB Ratio is 1.96. Mach7 Technologies' value of 1.84 is 6.1% below this benchmark. Historically, Mach7 Technologies' own PB Ratio has ranged from 0.44 to 14.85 over the past decade. While the company's 10-year median is 2.32 vs. the industry median of 1.96, Mach7 Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.96, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mach7 Technologies's current PB Ratio of 1.84 is 6.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Mach7 Technologies and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mach7 Technologies's current PB Ratio is 1.84, which is 21% below median its own 10-year median of 2.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mach7 Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mach7 Technologies (ASX:M7T) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.82, compared to a current price of A$0.31 — trading 62.8% below its estimated fair value. The current PB Ratio is 1.84, which is 21% below median its 10-year median of 2.32 and 6.1% below the Healthcare Providers & Services industry median of 1.96. Mach7 Technologies' overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Mach7 Technologies (ASX:M7T), the current PB Ratio is 1.84 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mach7 Technologies (ASX:M7T) Overvalued in 2026?
Based on GuruFocus' analysis, Mach7 Technologies stock appears to be undervalued.
The current stock price of A$0.31 is trading 62.8% below its estimated GF Value™ of A$0.82.
GuruFocus considers Mach7 Technologies to be Possible Value Trap.
Key valuation signals for ASX:M7T:
PB Ratio: 1.84 (21% below median its 10-year median of 2.32)
GF Value™: A$0.82 vs. price of A$0.31 (62.8% below fair value)
Industry Position: 6.1% below the Healthcare Providers & Services median (#282 of 611)
No single metric tells the full story. See the ASX:M7T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The company's vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
35GF Score
Get the complete analysis for ASX:M7T
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:M7T has been successfully added to your 
